Evidence map›Paper›PMID 23612498›Full record

ReviewCellular signalling2013

TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification.

Lauren M Workman, Hasem Habelhah

Open access · greenAbstract readReview
In one paragraph

Review in Cellular signalling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. The JNK Signaling Pathway in Renal Fibrosis.Frontiers in physiology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lauren M WorkmanInterdisciplinary Graduate Program in Molecular and Cellular Biology, University of Iowa, Iowa City, IA 52242, USA.
Hasem Habelhah
University of Iowa · US

Funding

RIP1 Cleavage by Caspase-8 is Essential for TRAIL-induced NF-kB ActivationR01CA138475 · NCI · UNIVERSITY OF IOWA · PI HABELHAH, HASEM · 2010 to 2014
$1.5M
NCI NIH HHS CA138475NCI NIH HHS R01 CA138475
6 · The paper itself

Abstract

TNFα is a pleotropic cytokine that plays a central role in the inflammatory response by activating the NF-κB signaling pathway, and is targeted in a range of chronic inflammatory diseases, underscoring the therapeutic importance of understanding its underlying molecular mechanisms. Although K63-linked ubiquitination of RIP1 by TRAF2/5 and cIAP1/2 was thought to serve as a scaffold to activate the NF-κB pathway, the recent accumulation of conflicting results has challenged the necessity of these proteins in NF-κB activation. In addition, several serine/threonine kinases have been implicated in TNFα-induced IKK activation; however, the targeted disruption of these kinases had no effect on transient IKK activation. The recent discovery of RIP1-dependent and -independent activation of the early and delayed phases of IKK and TRAF2 phosphorylation-dependent activation of the prolonged phase of IKK offers a reconciliatory model for the interpretation of contradictory results in the field. Notably, the TNFα-induced inflammatory response is not exclusively controlled by the NF-κB pathway but is subject to regulatory crosstalk between NF-κB and other context-dependent pathways. Thus further elucidation of these spatiotemporally-coordinated signaling mechanisms has the potential to provide novel molecular targets and therapeutic strategies for NF-κB intervention.

Indexed as

AnimalsCASP8 and FADD-Like Apoptosis Regulating ProteinHumansI-kappa B KinaseJNK Mitogen-Activated Protein KinasesNF-kappa BNuclear Pore Complex ProteinsProtein Processing, Post-TranslationalReactive Oxygen SpeciesReceptors, Tumor Necrosis Factor, Type IRNA-Binding ProteinsSignal TransductionTNF Receptor-Associated Factor 2AGFG1 protein, humanCASP8 and FADD-Like Apoptosis Regulating ProteinI-kappa B KinaseJNK Mitogen-Activated Protein KinasesNF-kappa BNuclear Pore Complex ProteinsReactive Oxygen SpeciesReceptors, Tumor Necrosis Factor, Type IRNA-Binding ProteinsTNF Receptor-Associated Factor 2

Identifiers

PMID23612498
PMCPMC3824607
OpenAlexW2000992351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.